Weston Case Nadherny is a Atlanta, Georgia based physiatrist who is specialized in Pain Management (PM&R). Active license number of Weston Case Nadherny as Physical Medicine & Rehabilitation (PM&R) is 100534 in Georgia.
Weston Case Nadherny provides a high level of care, either as a primary physician or consultant, for patients experiencing problems with acute, chronic or cancer pain in both hospital and ambulatory settings. Patient care needs may also be coordinated with other specialists.
Complete Profile:
Weston Case Nadherny speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Pain Management (PM&R)
Credentials:
MD
Gender:
Male
Practice Address:
21 Ortho Ln, Atlanta, Georgia, 30329-2315
Phone:
404-778-3350
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1881254050
NPI Enumeration Date:
19 Jun, 2019
NPI Last Update On:
27 Dec, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Weston Case Nadherny are as mentioned below.
License Number
Specialization
State
Status
100534
Physiatrist
Georgia
Primary
82028-20
Pain Management (PM&R)
Wisconsin
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
21 Ortho Ln, Atlanta, Georgia
Zip:
30329-2315
Phone Number:
404-778-3350
Fax Number:
--
Patients can reach Weston Case Nadherny at 21 Ortho Ln, Atlanta, Georgia or can call to book an appointment on 404-778-3350. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 July, 2025.